This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 21, 2011

Home   Membership   FAQ's   Bylaws    Mission Statement    Jobs   History   Contact Us


 


SGI Annual Scientific Meeting — March 21-24, 2012

Early-bird Registration Deadline: Feb. 17, 2012

Provisional Program Details

2012 SGI Meeting Registration Form

2012 SGI Meeting at a Glance

Record Number of Abstracts Submitted
The deadline for submission of abstracts for the 2012 SGI Annual Scientific Meeting has past and the final count of submitted abstracts was 1,159, which represents a record high for the SGI. We are now in the process of collating the abstracts and sending them for peer review. Many thanks to all of you who submitted abstracts or who supported the submission of abstracts. The high number of abstracts suggests that we will have an excellent attendance in San Diego, so please remember to register sooner than later to ensure you are able to reserve a hotel room at the SGI discounted rate.

SAVE THE DATE
Society for Gynecologic Investigation Summit 2012
Prematurity and Stillbirth
Antecedents, Mechanisms and Sequelae
Aug. 3-5, 2012
Brisbane Convention & Exhibit Centre
Queensland, Australia
Visit: www.uqccr.uq.edu.au

Speakers:
Professor John Challis
: University professor emeritus, University of Toronto; adjunct professor, University of Western Australia; past president SGI.
Professor Sir Peter Gluckman: Chief science advisor to the prime minister of New Zealand.
Professor Stephen Lye: Vice-chair, research and professor of obstetrics and gynecology at the University of Toronto; co-chair of the Centre for Women's and Infant's Health at Mount Sinai Hospital, Toronto; president, SGI.
Professor John Mattick: Executive director, Garvan Institute.
Professor Leslie Myatt: Professor of obstetrics and gynecology, co-director Center for Pregnancy and Newborn Research, University of Texas Health Science Center, San Antonio; past president, SGI.



Uterine transplants: A new frontier in science
The Indianapolis Star    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In the early days of infertility research, scientists — flush with the promise of transplant medicine — wondered whether replacing the uterus would help women who were unable to conceive. But less invasive treatments proved feasible, and such research fell by the wayside. Now, a handful of researchers, including some at the Indiana University School of Medicine, are exploring whether uterine transplants might be able to help women who lack a womb to bear children. More



Pregnancy stress may mean fewer boy babies
Futurity.org    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stress in the second and third months of pregnancy may affect the ratio of boys to girls being born, leading to a decline in the number of baby boys. The findings from a new study of pregnant women following the 2005 Tarapaca earthquake in Chile also confirms previous findings that stress can shorten pregnancies and increase the risk of pre-term births. The research, published online in the journal Human Reproduction, is the first to look at the impact of both the timing of the stress and the effect that stress might have on the ratio of male-to-female births. More

New HPV test more effective than Pap smear in detection of cervical cancer
HealthNews    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new DNA test that looks for the human papillomavirus has been found to detect precancerous lesions earlier than the traditional Pap smear, which could be more effective in the prevention of cervical cancer than having routine Pap smears alone. The findings come from a five-year study conducted by researchers from VU University Medical Center in Amsterdam. Details of the analysis appear in The Lancet Oncology. More

A look at the Plan B pill controversy
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a surprise development that riled some and pleased others, the emergency contraceptive drug Plan B One-Step — popularly called the morning-after pill — will remain available for girls 16 and younger by prescription only. The Food and Drug Administration had earlier announced its intentions to permit sale of the drug over-the-counter for all ages, but Health and Human Services Secretary Kathleen Sebelius overruled that decision. More



Study: Progesterone reduces number of preterm babies
The Detroit News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Preterm births, neonatal complications and healthcare costs are dramatically reduced when women with short cervixes are given a progesterone gel, according to a study announced by Michigan researchers at Wayne State University. The strategy can help prevent 45,000 preterm births annually and cut healthcare costs by $500 million, said Dr. Roberto Romero, the study's principal investigator and chief of the Perinatology Research Branch of the National Institutes of Health, hosted by WSU at Hutzel Women's Hospital in Detroit. More

Tiny Melinda, one of world's smallest newborns, beating odds, may go home soon
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Melinda Star Guido was supposed to be born Dec. 15. Instead, she came into the world 16 weeks early, one of the smallest premature babies ever to beat overwhelming odds and survive. The tiny fighter, only a little more than half a pound and the size of her doctor's hand at birth, now weighs 4 pounds. Doctors gave her no more than a 2 percent chance of survival, but she is thriving and could go home on New Year's Day. More

Canadian researchers see ovarian cancer vaccine breakthrough
The Vancouver Sun    Share    Share on FacebookTwitterShare on LinkedinE-mail article
British Columbia Cancer Agency researchers in Victoria believe they are nearing a vaccine for ovarian cancer, the most severe of gynecological cancers. Brad Nelson, a molecular and cellular biologist and project leader of the research at the BC Cancer Agency's Deeley Research Centre, said the team believes it is three to five years from clinical trials of a vaccine. Nelson said this development has been made possible by recent breakthroughs in DNA sequencing. "It's a whole new approach to cancer vaccines that's never been used before," he said. More

News from Reproductive Sciences

Dichloroacetate induces apoptosis of epithelial ovarian cancer cells through a mechanism involving modulation of oxidative stress
Reproductive Sciences, December 2011
Epithelial ovarian cancer (EOC) cells are under intrinsic oxidative stress, which alters metabolic activity and reduces apoptosis. Key oxidative stress enzymes, including myeloperoxidase (MPO) and inducible nitric oxide synthase (iNOS), are upregulated and colocalized in EOC cells. More.



Breast cancer brachytherapy may be overused
MedPage Today (Free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Many women who were not ideal candidates for accelerated partial breast irradiation based on treatment guidelines regularly receive the treatment, according to a population-based study. Between 2000 and 2007, 2.6 percent of nearly 140,000 U.S. women with nonmetastatic breast cancer underwent accelerated partial breast irradiation using brachytherapy and 65.8 percent of them were classified as "cautionary" or "unsuitable" for the procedure per American Society for Radiation Oncology guidelines, reported Dr. Jona Hattangadi from Brigham and Women's Hospital in Boston, and colleagues in the Journal of the National Cancer Institute. More

DHEA said to help menopausal symptoms, sex life
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The hormone DHEA has been found to help relieve menopausal symptoms in women, as well as helping them improve their sex lives, Italian researchers wrote in the Climacteric, the peer-reviewed journal of the International Menopause Society. Dehydroepiandrosterone, a steroid hormone secreted mainly by the adrenal glands, is the most abundant circulating steroid in humans. More

Endometriosis tied to higher risk of Crohn's disease, colitis
HealthDay via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Women with endometriosis may be up to 80 percent more likely to develop inflammatory bowel disease such as Crohn's disease or ulcerative colitis compared to women without the uterine disorder, according to a new long-term study. More

Indian doctors told not to use Letrozole for infertility
The Times of India    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administrations in India has alerted doctors to refrain from using the controversial drug Letrozole to treat infertility in women. The move came in the wake of the Indian government's decision to ban manufacture, sale and distribution of Letrozole. However, the drug will continue to be used in treatment of breast cancer in post-menopausal women. More



 
Eye on SGI
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Elizabeth Zavala, Content Editor, 469.420.2676   
Contribute news

This edition of Eye on SGI was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Dec. 21, 2011
Dec. 14, 2011
Dec. 7, 2011
Nov. 30, 2011



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063